Eurofins-Cerep SA (EPA:ALECR)

Market Cap	90.79M -12.6%
Revenue (ttm)	38.86M -8.4%
Net Income	6.16M -15.1%
EPS	n/a
Shares Out	5.04K
PE Ratio	14.74
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1
Open	n/a
Previous Close	18,000
Day's Range	n/a
52-Week Range	15,800 - 20,600
Beta	-0.02
RSI	64.62
Earnings Date	Apr 29, 2026

About Eurofins-Cerep

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company’s research services include compound management, and high-throughput screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France. Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1989
• Employees: 207
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALECR

Financial Performance

In 2024, Eurofins-Cerep's revenue was 40.49 million, a decrease of -8.13% compared to the previous year's 44.07 million. Earnings were 7.15 million, a decrease of -6.34%.